Wordt geladen...
Cancer nanomedicine: Is targeting our target?
Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.
Bewaard in:
| Gepubliceerd in: | Nat Rev Mater |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034892/ https://ncbi.nlm.nih.gov/pubmed/27668091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/natrevmats.2016.69 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|